Nutra Pharma Corp. Provides Update on Inventory and Fulfillment

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that they have completed the process of moving their inventory of their all-natural, non-addictive pain reliever, NyloxinA , into their Plantation, Florida facility ... (more)

http://www.biospace.com/news_story.aspx?StoryID=308415&full=1